scholarly journals Clinical Practice Patterns of Polycystic Ovary Syndrome Among Doctors of Different Specialties—An Indian Perspective

2020 ◽  
Vol 16 (2) ◽  
pp. 74
Author(s):  
Deep Dutta ◽  
Saptarshi Bhattacharya ◽  
Deepak Khandelwal ◽  
Sameer Aggarwal ◽  
Rajiv Singla ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Polycystic Ovary Syndrome ◽  
Practice Patterns ◽  
Polycystic Ovary ◽  
Ovary Syndrome ◽  
Clinical Practice Patterns ◽  
Indian Perspective

scholarly journals Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice

Clinics ◽  
2015 ◽  
Vol 70 (11) ◽  
pp. 765-769 ◽  
Author(s):  
AS Melo ◽  
RA Ferriani ◽  
PA Navarro
Keyword(s):  
Clinical Practice ◽  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Ovary Syndrome

scholarly journals Adiponectin and Polycystic Ovary Syndrome

2010 ◽  
Vol 12 (1) ◽  
pp. 62-72 ◽  
Author(s):  
Susan W. Groth
Keyword(s):  
Insulin Resistance ◽  
Metabolic Syndrome ◽  
Clinical Practice ◽  
Polycystic Ovary Syndrome ◽  
Disease Risk ◽  
Polycystic Ovary ◽  
Reproductive Age ◽  
Ovary Syndrome ◽  
Increased Risk

Introduction. Polycystic ovary syndrome (PCOS) has a prevalence of 5—8% in women of reproductive age. Women with PCOS have an increased risk of metabolic syndrome and associated comorbidities. Adiponectin is a circulating protein produced by adipocytes. Circulating levels of adiponectin are inversely related to adipocyte mass. Low levels occur with insulin resistance, type 2 diabetes, metabolic syndrome, and obesity-related cardiovascular disease. This article reviews the literature on the link between adiponectin and PCOS and the potential use of adiponectin as a biomarker for PCOS. Method. Data-based studies on adiponectin and PCOS and adiponectin measurement were identified through the Medline (1950—2009) and ISI Web of Knowledge (1973—2009) databases. Results. Fifteen studies related to adiponectin and PCOS met inclusion criteria and were included in this review. These studies present evidence that adiponectin is linked to insulin resistance, insulin sensitivity, body mass index (BMI), and adiposity. In women with PCOS, lower levels, as opposed to higher levels, of adiponectin occur in the absence of adiposity. Conclusion. The relationships between adiponectin and insulin resistance and sensitivity, metabolic syndrome, and BMI in women with PCOS suggest that adiponectin potentially could serve as a marker for disease risk and provide opportunity for earlier intervention if knowledge is successfully translated from laboratory to clinical practice. However, further study of the relationship between adiponectin and PCOS is required before there can be direct application to clinical practice.

Sign in / Sign up

Export Citation Format

Share Document